The present invention is directed to quinazolinone compounds of the formula I: ##STR00001## wherein R.sup.1, R.sup.2, R.sup.3, X.sup.1, X.sup.2 X.sup.3 are defined herein. These compounds are antagonists of T-type calcium channels, and are useful in the treatment or prevention of disorders and diseases in which T-type calcium channels are involved. The invention is also directed to pharmaceutical compositions comprising these compounds and the use of these compounds and compositions in the prevention or treatment of such diseases in which T-type calcium channels are involved.

 
Web www.patentalert.com

< 3-.beta.-D-ribofuranosylthiazolo[4,5-d]pyrimidine nucleosides and uses thereof

< Substituted thieno[3,2-D]pyrimidines as non-basic melanin concentrating hormone receptor-1 antagonists

> Processes for preparing venlafaxine and venlafaxine hydrochloride of form I

> Acyloxyalkyl carbamate prodrugs, methods of synthesis and use

~ 00621